# A functional module-based exploration between inflammation and cancer in esophagus

**Authors:** Nannan Liu, Chunhua Li, Yan Huang, Ying Yi, Wanlan Bo, Chunmiao Li, Yue Li, Yongfei Hu, Kongning Li, Hong Wang, Liwei Zhuang, Huihui Fan, Dong Wang

PMC · DOI: 10.1038/srep15340 · Scientific Reports · 2015-10-22

## TL;DR

This study explores how inflammation and cancer in the esophagus are linked through shared molecular functions and regulatory mechanisms.

## Contribution

The paper introduces a functional module-based approach to uncover molecular links between inflammation and esophageal cancer.

## Key findings

- Common genes and interactions are key in linking inflammation and cancer in the esophagus.
- Significant crosstalk modules and pivot regulators help bridge inflammation and cancer processes.
- Functional module analysis reveals distinct parts of the molecular network connecting these diseases.

## Abstract

Inflammation contributing to the underlying progression of diverse human cancers has been generally appreciated, however, explorations into the molecular links between inflammation and cancer in esophagus are still at its early stage. In our study, we presented a functional module-based approach, in combination with multiple data resource (gene expression, protein-protein interactions (PPI), transcriptional and post-transcriptional regulations) to decipher the underlying links. Via mapping differentially expressed disease genes, functional disease modules were identified. As indicated, those common genes and interactions tended to play important roles in linking inflammation and cancer. Based on crosstalk analysis, we demonstrated that, although most disease genes were not shared by both kinds of modules, they might act through participating in the same or similar functions to complete the molecular links. Additionally, we applied pivot analysis to extract significant regulators for per significant crosstalk module pair. As shown, pivot regulators might manipulate vital parts of the module subnetworks, and then work together to bridge inflammation and cancer in esophagus. Collectively, based on our functional module analysis, we demonstrated that shared genes or interactions, significant crosstalk modules, and those significant pivot regulators were served as different functional parts underlying the molecular links between inflammation and cancer in esophagus.

## Linked entities

- **Diseases:** cancer (MONDO:0004992), esophageal cancer (MONDO:0007576)

## Full-text entities

- **Genes:** CARD17P (caspase recruitment domain family member 17, pseudogene) [NCBI Gene 440068] {aka CARD17, INCA}, SMARCA4 (SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4) [NCBI Gene 6597] {aka BAF190, BAF190A, BRG1, CSS4, MRD16, OTSC12}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, GAD1 (glutamate decarboxylase 1) [NCBI Gene 2571] {aka CPSQ1, DEE89, GAD, GAD-67, SCP}, DSC2 (desmocollin 2) [NCBI Gene 1824] {aka ARVD11, CDHF2, DG2, DGII/III, DSC3}, JAK2 (Janus kinase 2) [NCBI Gene 3717] {aka JTK10}, PKP2 (plakophilin 2) [NCBI Gene 5318] {aka ARVD9}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, ELMO1 (engulfment and cell motility 1) [NCBI Gene 9844] {aka CED-12, CED12, ELMO-1}, MIR30B (microRNA 30b) [NCBI Gene 407030] {aka MIRN30B, mir-30b}, PTK2 (protein tyrosine kinase 2) [NCBI Gene 5747] {aka FADK, FADK 1, FAK, FAK1, FRNK, PPP1R71}, PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2) [NCBI Gene 5296] {aka MPPH, MPPH1, P85B, p85, p85-BETA, p85beta}, SPARC (secreted protein acidic and cysteine rich) [NCBI Gene 6678] {aka BM-40, OI17, ON, ONT}, TMPRSS11A (transmembrane serine protease 11A) [NCBI Gene 339967] {aka ECRG1, HATL1, HESP}, MIR26B (microRNA 26b) [NCBI Gene 407017] {aka MIRN26B, hsa-mir-26b, miR-26b}, RAC1 (Rac family small GTPase 1) [NCBI Gene 5879] {aka MIG5, MRD48, Rac-1, TC-25, p21-Rac1}, MIR29A (microRNA 29a) [NCBI Gene 407021] {aka MIRN29, MIRN29A, hsa-mir-29, hsa-mir-29a, miRNA29A, mir-29a}, MIR155 (microRNA 155) [NCBI Gene 406947] {aka MIRN155, miRNA155, mir-155}, IRS1 (insulin receptor substrate 1) [NCBI Gene 3667] {aka HIRS-1}, MIR30C1 (microRNA 30c-1) [NCBI Gene 407031] {aka MIRN30C1, mir-30c-1}, MIR200C (microRNA 200c) [NCBI Gene 406985] {aka MIRN200C, mir-200c}, MIR186 (microRNA 186) [NCBI Gene 406962] {aka MIRN186, miR-186}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, MIR126 (microRNA 126) [NCBI Gene 406913] {aka MIRN126, miRNA126, mir-126}, MIR181D (microRNA 181d) [NCBI Gene 574457] {aka MIRN181D, mir-181d}, MIR181C (microRNA 181c) [NCBI Gene 406957] {aka MIRN181C, mir-181c}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, KLF4 (KLF transcription factor 4) [NCBI Gene 9314] {aka EZF, GKLF}, MIR27B (microRNA 27b) [NCBI Gene 407019] {aka MIR-27b, MIRN27B, miRNA27B}, DSG2 (desmoglein 2) [NCBI Gene 1829] {aka CDHF5, HDGC}, IRS2 (insulin receptor substrate 2) [NCBI Gene 8660] {aka IRS-2}, CEBPA (CCAAT enhancer binding protein alpha) [NCBI Gene 1050] {aka C/EBP-alpha, CEBP}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, COX2 (cytochrome c oxidase subunit II) [NCBI Gene 4513] {aka COII, MTCO2}, MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599] {aka JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8}, JAK1 (Janus kinase 1) [NCBI Gene 3716] {aka AIIDE, JAK1A, JAK1B, JTK3}
- **Diseases:** Inflammation (MESH:D007249), gastric cancer (MESH:D013274), head and neck (MESH:D006258), endometrial cancer (MESH:D016889), ovarian cancer (MESH:D010051), tumorigenesis of esophagus (MESH:D063646), metastasis (MESH:D009362), Cancer (MESH:D009369), dysplasia (MESH:D015792), EC (MESH:D005955), breast cancer (MESH:D001943), melanoma (MESH:D008545), glioma (MESH:D005910), lung damage (MESH:D008171), Barrett-like metaplasia (MESH:D001471), infections (MESH:D007239), Esophageal cancer (MESH:D004938), Esophagitis (MESH:D004941), lung cancer (MESH:D008175), oesophagitis (MESH:D000077277), esophageal diseases (MESH:D004935), gastrointestinal cancer (MESH:D005770), death (MESH:D003643), hepatocellular cancer (MESH:D006528)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** Arg290Gln

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4614801/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4614801/full.md

## References

74 references — full list in the complete paper: https://tomesphere.com/paper/PMC4614801/full.md

---
Source: https://tomesphere.com/paper/PMC4614801